Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/18/17 → 07/23/19 |
Funding
- InVentiv Health Clinical LLC: $8,687.50
Bristol-Meyers Squibb: Determining Change in Cardiovascular and Metabolic Risks in Patients with Chronic Myeliod Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Salman, Huda (CoPI)
Project: Research